DEA designates bromazolam as Schedule I, boosting enforcement and awareness of its deadly risks after push from 22-state ...

Information from CMS’s published explanations of the Medicare Drug Price Negotiation Program negotiated prices for 2027 will ...

The principle that medicines should not reach patients without strong safety guardrails forms the bedrock of the US Food and Drug Administration (FDA). The FDA shapes decisions about which medicines ...

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the deals with the Trump administration on some drug prices versus others.

AMED will need to make up to $40,000 worth of changes to comply with a new national requirement that ambulance services be ...

(Bloomberg) -- The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic medications in a bid to ...